Luka Krstulović

548 total citations
17 papers, 449 citations indexed

About

Luka Krstulović is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Luka Krstulović has authored 17 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Toxicology. Recurrent topics in Luka Krstulović's work include Synthesis and biological activity (7 papers), Click Chemistry and Applications (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Luka Krstulović is often cited by papers focused on Synthesis and biological activity (7 papers), Click Chemistry and Applications (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Luka Krstulović collaborates with scholars based in Croatia, United Kingdom and Kosovo. Luka Krstulović's co-authors include Miroslav Bajić, Kristina Starčević, Maja Maurić, Tomislav Mašek, Željko Mikulec, Zvonko Stojević, Silvana Raić‐Malić, Andrea Bistrović, Sanja Koštrun and Ljubica Glavaš‐Obrovac and has published in prestigious journals such as Molecules, European Journal of Medicinal Chemistry and Journal of the Science of Food and Agriculture.

In The Last Decade

Luka Krstulović

17 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luka Krstulović Croatia 12 207 113 112 60 47 17 449
Rong‐Mei Gao China 15 195 0.9× 227 2.0× 48 0.4× 64 1.1× 22 0.5× 44 599
Reham A. I. Abou‐Elkhair Egypt 13 72 0.3× 93 0.8× 217 1.9× 173 2.9× 31 0.7× 32 512
Bipin Vaidya South Korea 11 114 0.6× 79 0.7× 38 0.3× 53 0.9× 80 1.7× 19 358
Mahesh C. Sharma India 13 112 0.5× 117 1.0× 27 0.2× 117 1.9× 19 0.4× 30 487
Ahmad Ebadi Iran 12 147 0.7× 219 1.9× 20 0.2× 48 0.8× 10 0.2× 50 484
Yingying Cao China 10 60 0.3× 161 1.4× 28 0.3× 57 0.9× 4 0.1× 24 460
Liping Luo China 9 23 0.1× 158 1.4× 49 0.4× 40 0.7× 29 0.6× 20 362
Valentina Noemi Madia Italy 18 284 1.4× 288 2.5× 7 0.1× 118 2.0× 48 1.0× 39 802
Huynh Thi Phuong Loan Vietnam 7 57 0.3× 68 0.6× 22 0.2× 85 1.4× 11 0.2× 27 375
María Teresa Garzón Martínez Mexico 4 52 0.3× 105 0.9× 13 0.1× 61 1.0× 96 2.0× 18 326

Countries citing papers authored by Luka Krstulović

Since Specialization
Citations

This map shows the geographic impact of Luka Krstulović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luka Krstulović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luka Krstulović more than expected).

Fields of papers citing papers by Luka Krstulović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luka Krstulović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luka Krstulović. The network helps show where Luka Krstulović may publish in the future.

Co-authorship network of co-authors of Luka Krstulović

This figure shows the co-authorship network connecting the top 25 collaborators of Luka Krstulović. A scholar is included among the top collaborators of Luka Krstulović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luka Krstulović. Luka Krstulović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Krstulović, Luka, Vesna Rastija, Laís Pessanha de Carvalho, et al.. (2024). Design, Synthesis, Antitumor, and Antiplasmodial Evaluation of New 7-Chloroquinoline–Benzimidazole Hybrids. Molecules. 29(13). 2997–2997. 4 indexed citations
3.
Krstulović, Luka, Marijana Jukić, Vesna Rastija, et al.. (2023). Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking. Molecules. 28(2). 540–540. 14 indexed citations
4.
Krstulović, Luka, et al.. (2021). An aromatic imidazoline derived from chloroquinoline triggers cell cycle arrest and inhibits with high selectivity the Trypanosoma cruzi mammalian host-cells infection. PLoS neglected tropical diseases. 15(11). e0009994–e0009994. 3 indexed citations
5.
Bistrović, Andrea, Luka Krstulović, Sanja Koštrun, et al.. (2020). Design, synthesis, antitrypanosomal activity, DNA/RNA binding and in vitro ADME profiling of novel imidazoline-substituted 2-arylbenzimidazoles. European Journal of Medicinal Chemistry. 207. 112802–112802. 20 indexed citations
6.
Bistrović, Andrea, Luka Krstulović, Martin C. Taylor, et al.. (2019). Novel symmetric bis-benzimidazoles: Synthesis, DNA/RNA binding and antitrypanosomal activity. European Journal of Medicinal Chemistry. 173. 63–75. 14 indexed citations
7.
Bistrović, Andrea, Luka Krstulović, Domagoj Drenjančević, et al.. (2018). Synthesis, anti-bacterial and anti-protozoal activities of amidinobenzimidazole derivatives and their interactions with DNA and RNA. Journal of Enzyme Inhibition and Medicinal Chemistry. 33(1). 1323–1334. 33 indexed citations
8.
Bistrović, Andrea, Luka Krstulović, Anja Harej, et al.. (2017). Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer. European Journal of Medicinal Chemistry. 143. 1616–1634. 93 indexed citations
9.
Krstulović, Luka, et al.. (2017). New quinoline-arylamidine hybrids: Synthesis, DNA/RNA binding and antitumor activity. European Journal of Medicinal Chemistry. 137. 196–210. 22 indexed citations
10.
Krstulović, Luka, et al.. (2017). Synthesis and In vitro Activity of N-sulfonylamidine-derived Pyrimidine Analogues. Croatica Chemica Acta. 90(4). 2 indexed citations
11.
Jukić, Marijana, et al.. (2016). Antitumor activity of 3,4-ethylenedioxythiophene derivatives and quantitative structure-activity relationship analysis. Journal of Molecular Structure. 1133. 66–73. 12 indexed citations
12.
Kovačević, Borislav, et al.. (2015). Mass Spectrometry and Theoretical Studies on N–C Bond Cleavages in the N-Sulfonylamidino Thymine Derivatives. Journal of the American Society for Mass Spectrometry. 26(5). 833–842. 3 indexed citations
13.
Starčević, Kristina, Luka Krstulović, Maja Maurić, et al.. (2014). Production performance, meat composition and oxidative susceptibility in broiler chicken fed with different phenolic compounds. Journal of the Science of Food and Agriculture. 95(6). 1172–1178. 150 indexed citations
14.
Mekinić, Ivana Generalić, Danijela Skroza, Ivica Ljubenkov, et al.. (2014). Phenolic Acids Profile, Antioxidant and Antibacterial Activity of Chamomile, Common Yarrow and Immortelle (Asteraceae). Natural Product Communications. 9(12). 1745–8. 27 indexed citations
15.
Mašek, Tomislav, et al.. (2013). Cow colostrum and early milk enriched with eicosapentaenoic and docosahexaenoic fatty acid. European Food Research and Technology. 238(4). 635–640. 14 indexed citations
16.
Krstulović, Luka, et al.. (2012). Synthesis of Novel Aliphatic N-sulfonylamidino Thymine Derivatives by Cu(I)-catalyzed Three-component Coupling Reaction. Croatica Chemica Acta. 85(4). 525–534. 10 indexed citations
17.
Mastelić, Josip, Igor Jerković, Ivica Blažević, Ani Radonić, & Luka Krstulović. (2008). Hydrodistillation–adsorption method for the isolation of water-soluble, non-soluble and high volatile compounds from plant materials. Talanta. 76(4). 885–891. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026